BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 32621011)

  • 1. Hybrid TRUS/CT with optical tracking for target delineation in image-guided adaptive brachytherapy for cervical cancer.
    Smet S; Nesvacil N; Knoth J; Sturdza A; Najjari-Jamal D; Jelinek F; Kronreif G; Pötter R; Widder J; Kirisits C; Schmid MP
    Strahlenther Onkol; 2020 Nov; 196(11):983-992. PubMed ID: 32621011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transrectal ultrasound for image-guided adaptive brachytherapy in cervix cancer - An alternative to MRI for target definition?
    Schmid MP; Nesvacil N; Pötter R; Kronreif G; Kirisits C
    Radiother Oncol; 2016 Sep; 120(3):467-472. PubMed ID: 26921168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of Magnetic Resonance Imaging Without or With Applicator in Place for Target Definition in Cervix Cancer Brachytherapy.
    Pötter R; Federico M; Sturdza A; Fotina I; Hegazy N; Schmid M; Kirisits C; Nesvacil N
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):588-97. PubMed ID: 26867887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Prospective Comparison of Computed Tomography with Transrectal Ultrasonography Assistance and Magnetic Resonance Imaging-Based Target-Volume Definition During Image Guided Adaptive Brachytherapy for Cervical Cancers.
    Mahantshetty U; Naga Ch P; Khadanga CR; Gudi S; Chopra S; Gurram L; Jamema S; Ghadi Y; Shrivastava S
    Int J Radiat Oncol Biol Phys; 2018 Dec; 102(5):1448-1456. PubMed ID: 30146092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffusion-weighted MRI in image-guided adaptive brachytherapy: Tumor delineation feasibility study and comparison with GEC-ESTRO guidelines.
    Schernberg A; Balleyguier C; Dumas I; Gouy S; Escande A; Bentivegna E; Morice P; Deutsch E; Haie-Meder C; Chargari C
    Brachytherapy; 2017; 16(5):956-963. PubMed ID: 28673762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining transrectal ultrasound and CT for image-guided adaptive brachytherapy of cervical cancer: Proof of concept.
    Nesvacil N; Schmid MP; Pötter R; Kronreif G; Kirisits C
    Brachytherapy; 2016; 15(6):839-844. PubMed ID: 27693172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer.
    Tanderup K; Fokdal LU; Sturdza A; Haie-Meder C; Mazeron R; van Limbergen E; Jürgenliemk-Schulz I; Petric P; Hoskin P; Dörr W; Bentzen SM; Kirisits C; Lindegaard JC; Pötter R
    Radiother Oncol; 2016 Sep; 120(3):441-446. PubMed ID: 27350396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A volumetric analysis of GTV
    Jastaniyah N; Yoshida K; Tanderup K; Lindegaard JC; Sturdza A; Kirisits C; Šegedin B; Mahantshetty U; Rai B; Jürgenliemk-Schulz IM; Haie-Meder C; Banerjee S; Pötter R;
    Radiother Oncol; 2016 Sep; 120(3):404-411. PubMed ID: 27452409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
    Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
    Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of CTV
    Mendez LC; Ravi A; Martell K; Raziee H; Alayed Y; Wronski M; Paudel M; Barnes E; Taggar A; Wong CS; Leung E
    Radiat Oncol; 2020 Apr; 15(1):73. PubMed ID: 32252792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vienna-II ring applicator for distal parametrial/pelvic wall disease in cervical cancer brachytherapy: An experience from two institutions: Clinical feasibility and outcome.
    Mahantshetty U; Sturdza A; Naga Ch P; Berger D; Fortin I; Motisi L; Schmid MP; Aravindakshan D; Ghadi Y; Swamidas JV; Chopra S; Gurram L; Nesvacil N; Kirisits C; Pötter R
    Radiother Oncol; 2019 Dec; 141():123-129. PubMed ID: 31495516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study of DWI, DCE-MRI and FDG PET imaging for target delineation in brachytherapy for cervical cancer.
    Han K; Croke J; Foltz W; Metser U; Xie J; Shek T; Driscoll B; Ménard C; Vines D; Coolens C; Simeonov A; Beiki-Ardakani A; Leung E; Levin W; Fyles A; Milosevic MF
    Radiother Oncol; 2016 Sep; 120(3):519-525. PubMed ID: 27528120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apparent diffusion coefficients in GEC ESTRO target volumes for image guided adaptive brachytherapy of locally advanced cervical cancer.
    Haack S; Pedersen EM; Jespersen SN; Kallehauge JF; Lindegaard JC; Tanderup K
    Acta Oncol; 2010 Oct; 49(7):978-83. PubMed ID: 20831485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective intra/inter-observer evaluation of pre-brachytherapy cervical cancer tumor width measured in TRUS and MR imaging.
    Federico M; Hernandez-Socorro CR; Ribeiro I; Martin JG; Oramas MDR; Saez-Bravo ML; Jimenez PCL
    Radiat Oncol; 2019 Oct; 14(1):173. PubMed ID: 31585543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommendations for high-risk clinical target volume definition with computed tomography for three-dimensional image-guided brachytherapy in cervical cancer patients.
    Ohno T; Wakatsuki M; Toita T; Kaneyasu Y; Yoshida K; Kato S; Ii N; Tokumaru S; Ikushima H; Uno T; Noda SE; Kazumoto T; Harima Y;
    J Radiat Res; 2017 May; 58(3):341-350. PubMed ID: 27837120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utrecht Interstitial Applicator Shifts and DVH Parameter Changes in 3D CT-based HDR Brachytherapy of Cervical Cancer.
    Shi D; He MY; Zhao ZP; Wu N; Zhao HF; Xu ZJ; Cheng GH
    Asian Pac J Cancer Prev; 2015; 16(9):3945-9. PubMed ID: 25987066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI-guided adaptive brachytherapy for locally advanced cervix cancer: Treatment outcomes from a single institution in Hong Kong.
    Wu PY; Wong TPW; Yip YYC; Chang TYA; Chan LKL; Lee MCH; Law LYA; Yeung MWR; Soong SI
    Brachytherapy; 2019; 18(2):171-179. PubMed ID: 30581053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hybrid (CT/MRI based) vs. MRI only based image-guided brachytherapy in cervical cancer: Dosimetry comparisons and clinical outcome.
    Choong ES; Bownes P; Musunuru HB; Rodda S; Richardson C; Al-Qaisieh B; Swift S; Orton J; Cooper R
    Brachytherapy; 2016; 15(1):40-8. PubMed ID: 26602964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study.
    Pötter R; Tanderup K; Schmid MP; Jürgenliemk-Schulz I; Haie-Meder C; Fokdal LU; Sturdza AE; Hoskin P; Mahantshetty U; Segedin B; Bruheim K; Huang F; Rai B; Cooper R; van der Steen-Banasik E; Van Limbergen E; Pieters BR; Tan LT; Nout RA; De Leeuw AAC; Ristl R; Petric P; Nesvacil N; Kirchheiner K; Kirisits C; Lindegaard JC;
    Lancet Oncol; 2021 Apr; 22(4):538-547. PubMed ID: 33794207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Accuracy of different image registration methods in image-guided adaptive brachytherapy for cervical cancer].
    Peng Q; Peng Y; Zhu J; Cai M; Zhou L
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Nov; 38(11):1344-1348. PubMed ID: 30514683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.